DR REDDYS LABORATORIES LTD

Business Nature: Manufacturer

Company Overview:

Dr. Reddys Laboratories Ltd is a prominent multinational pharmaceutical company with a significant presence in Indonesia. The company operates as a manufacturer, focusing on the production, development, and distribution of high-quality, affordable medicines. In Indonesia, the company is committed to improving patient access to healthcare by providing a wide range of therapeutic solutions, including generic drugs, active pharmaceutical ingredients (APIs), and biosimilars. Leveraging global research and development capabilities, the Indonesian branch adheres to international manufacturing standards to ensure the safety and efficacy of its pharmaceutical products for the local market.

Dr. Reddys Laboratories Ltd in Indonesia offers a diverse portfolio primarily focused on oncology, gastroenterology, cardiovascular health, and pain management. Their product range includes the following:

Oncology and Hematology Products

Bendamustine

Capecitabine

Docetaxel

Gemcitabine

Irinotecan

Lenalidomide

Oxaliplatin

Paclitaxel

Pemetrexed

Gastroenterology Products

Esomeprazole

Pantoprazole

Rabeprazole

Cardiovascular Products

Atorvastatin

Clopidogrel

Rosuvastatin

Pain Management and Anti-inflammatory Products

Diclofenac

Ibuprofen

Naproxen

Other Therapeutic Areas

Anti-diabetic medications

Anti-infectives

Dermatological preparations

Please note that the availability of specific products may vary depending on local regulatory approvals and current distribution agreements within Indonesia. For the most accurate and up-to-date list of registered products, you may refer to the official website of the Indonesian National Agency of Drug and Food Control (BPOM).